Bryan Liu
Ahụmịhe ọrụ:
Onyeisi nke Ngalaba Mba Nile, Ụlọ Ọgwụ Ọdụ Ụgbọelu TianJin Cancer Hospital
Onye otu Kọmitii Omume na Ụlọ Ọgwụ Ọdụ Ụgbọelu TianJin Cancer Hospital
Onye hiwere Biocus Medical Group na CGT Centers
Prọfesọ nke Njikwa Nnyocha Sayensị na Ụlọ Akwụkwọ nke Sayensị Ndụ, Beijing Institute of Technology
Onye ndu otu ndị ọrụ nke Kọmitii Ọkachamara Ahụike Cellular na China Association for the Promotion of Human Health Technology
Ngalaba Ọkachamara:
Ọ bụ ọkachamara n'ọgwụ chemotherapy, ọgwụgwọ ezubere iche, ọgwụgwọ CAR-T, na immunotherapy maka ọrịa kansa ọbara.
Ahụmịhe sara mbara nke ahụike nwere nsogbu ọbara dị njọ dịka leukemia na-adịghị ike ma na-alaghachi azụ, lymphoma, na multiple myeloma, ọkachamara n'ịchịkwa ikpe ndị siri ike ma sie ike.
Enwetara nnukwu ọganihu n'ịgwọ ọrịa ndị na-apụtaghachi ugboro ugboro site na iji ọgwụ mgbochi mkpụrụ ndụ maka ndị ọrịa mba ụwa, nke gosiri na ọ gara nke ọma n'ọgwụgwọ.
Na-eje ozi dịka onye ndụmọdụ maka ọgwụgwọ ọrịa mgbochi ọrịa maka ụlọ ọgwụ Apollo dị na India, na-akwalite mmekorita ahụike gafere ókèala.
Ahụmịhe Ahụike:
Ihe karịrị afọ iri nke ahụmịhe ahụike n'ịchọpụta na ịgwọ ọrịa hematological dị mgbagwoju anya.
O sonye na ihe karịrị ikpe 300 nke ọgwụgwọ sel maka ndị ọrịa mba ụwa, gụnyere ikpe nke leukemia ugboro ugboro, lymphoma, Neuroblastoma, multiple myeloma, MG, SLE, SSC, Thalassemia, SCD, na TDT.
Ngalaba Nnyocha Sayensị:
E tinyere uche na ọgwụgwọ immunotherapy cellular na ọgwụgwọ mkpụrụ ndụ ihe nketa ruo afọ iri abụọ.
Enwetara m nnukwu nsonaazụ na ọgwụgwọ CAR-T, ọgwụgwọ TILs, ọgwụgwọ NK, na ọgwụgwọ mkpụrụ ndụ ihe nketa.
E hiwere ụlọọgwụ anọ na-agwọ ọrịa mkpụrụ ndụ na mkpụrụ ndụ ihe nketa (CGT) na Beijing na Tianjin.
